SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-022733
Filing Date
2016-08-04
Accepted
2016-08-04 16:38:51
Documents
47
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q acad-10q_20160630.htm 10-Q 1260464
2 EX-10.1 acad-ex10_319.htm EX-10 17434
3 EX-31.1 acad-ex31_6.htm EX-31 9127
4 EX-32.1 acad-ex32_7.htm EX-32 6387
  Complete submission text file 0001564590-16-022733.txt   3590134

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT acad-20160630.xml EX-101.INS 641701
6 XBRL TAXONOMY EXTENSION SCHEMA acad-20160630.xsd EX-101.SCH 23248
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acad-20160630_cal.xml EX-101.CAL 39688
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acad-20160630_def.xml EX-101.DEF 47717
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20160630_lab.xml EX-101.LAB 193311
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20160630_pre.xml EX-101.PRE 141611
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 161808041
SIC: 2834 Pharmaceutical Preparations